Connor, Clark & Lunn Investment Management Ltd. Icad Inc Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $21.1 Billion
- Q1 2025
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Icad Inc stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 19,644 shares of ICAD stock, worth $77,004. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,644Holding current value
$77,004% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ICAD
# of Institutions
64Shares Held
8.01MCall Options Held
67KPut Options Held
40.2K-
Vanguard Group Inc Valley Forge, PA1.21MShares$4.74 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY919KShares$3.6 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT782KShares$3.06 Million0.21% of portfolio
-
First Eagle Investment Management, LLC725KShares$2.84 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny656KShares$2.57 Million0.0% of portfolio
About ICAD INC
- Ticker ICAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 25,333,900
- Market Cap $99.3M
- Description
- iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...